Virbac SA (V16 F) stock market data APIs
€358.0351
3.08(0.9%)
as of January 21, 2026
Try our APIs with
free plan!
Virbac SA Financial Data Overview
Price chart is built with
Anychart
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific. The company offers a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products. It serves veterinarians, farmers, and pet owners. The company was founded in 1968 and is headquartered in Carros, France.
Prev. Close
358.0351
Open
361.1128
High
361.3848
Low
357.5413
52 wk Range
264.2932-368
Market Cap
3 003 M
P/E Ratio
22.5756
Shares Outstanding
8 378 K
Revenue
1 433 M
Dividends (Yield)
0.004
Beta
0.891
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Virbac SA data using free add-ons & libraries
Get Virbac SA Fundamental Data
Virbac SA Fundamental data includes:
- Net Revenue: 1 433 M
- EBITDA: 262 M
- Earnings Per Share: 15
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Virbac SA News
New
Virbac: solid 2025 dynamic with annual revenue up +7.9% at CERS3; with strong momentum in key categories and countries
Virbac Full-year 2025 revenue reached €1,465m : +7.9% at constant exchange rate and scope (CERS) vs 2024 +4.8% at actual rates impacted by significant currency headwinds, particularly in Latin Ame...
Is Virbac (ENXTPA:VIRP) Offering Value After Strong Multi Year Share Price Gains
If you are wondering whether Virbac at €361.50 is offering fair value or an opportunity, the key is to understand what the current share price actually reflects. The stock has recorded returns of 1....
Virbac : Declaration of the number of shares and voting rights 12/2025
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the...
Veterinary Infectious Disease Diagnostics Market Forecast, 2025-2035, Featuring IDEXX Labs, Zoetis, Thermo Fisher Scientific, Virbac, bioMerieux and More
Company Logo Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Veterinary Infectious Disease Diagnostics Market - A Global and Regional Analysis: Focus on Technology, Product, Animal Type, Infection Typ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
